Covid-19 Superspreading Events Network Analysis from Agent-Based Model with Mobility Restriction

COVID-19 pandemic is an immediate major public health concern. The search for the understanding of the disease spreading made science around the world turn to epidemiological studies, especially compartmental models. However, an interesting approach in epidemiological modeling nowadays is to use network models, which allow us to consider a heterogeneous population and to evaluate the role of superspreaders in this population. In this work, we implemented an agent-based model using probabilistic cellular automata to simulate SIR (Susceptible-Infected-Recovered) dynamics and COVID-19 infection parameters. The agents execute a random walk along the sites and have a probability to get the infection when share the same site of an infected one. To evaluate the spreading, we built the transmission network and measured the degree distribution, betweenness and closeness centrality. The results displayed for different levels of mobility restriction show that the degree reduces as the mobility reduces, but there is an increase of betweenness and closeness for some network nodes. Among other measures, as testing and tracing contacts, this study can bring important insights for the analysis of the disease dynamics and the role of superspreading events, contributing to the understanding of how to manage the mobility during a highly infectious pandemic as COVID-19.

[1]  Sunhwa Choi,et al.  Estimating the reproductive number and the outbreak size of COVID-19 in Korea , 2020, Epidemiology and Health.

[2]  Jessica T Davis,et al.  The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.

[3]  R. Stein Super-spreaders in infectious diseases , 2011, International Journal of Infectious Diseases.

[4]  P. E. Kopp,et al.  Superspreading and the effect of individual variation on disease emergence , 2005, Nature.

[5]  Xiaolong Zheng,et al.  Heterogeneous and Stochastic Agent-Based Models for Analyzing Infectious Diseases' Super Spreaders , 2013, IEEE Intelligent Systems.

[6]  S. Stramer,et al.  COVID-19 and Blood Safety: Help with a Dilemma , 2020, Transfusion Medicine Reviews.

[7]  Min Zhao,et al.  A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations , 2020, General Psychiatry.

[8]  T. West,et al.  Covid-19 in Critically Ill Patients in the Seattle Region — Case Series , 2020, The New England journal of medicine.

[9]  James O Lloyd-Smith,et al.  Dynamically Modeling SARS and Other Newly Emerging Respiratory Illnesses: Past, Present, and Future , 2005, Epidemiology.

[10]  Centers for Disease Control and Prevention CDC COVID-19 Response Team Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[11]  Hohyung Ryu,et al.  Agent-Based Modeling for Super-Spreading Events: A Case Study of MERS-CoV Transmission Dynamics in the Republic of Korea , 2018, International journal of environmental research and public health.

[12]  J. Rocklöv,et al.  The reproductive number of COVID-19 is higher compared to SARS coronavirus , 2020, Journal of travel medicine.

[13]  M. Agha,et al.  The socio-economic implications of the coronavirus pandemic (COVID-19): A review , 2020, International Journal of Surgery.

[14]  P. Hiremath,et al.  COVID 19: Impact of lock-down on mental health and tips to overcome , 2020, Asian Journal of Psychiatry.

[15]  Hannah R. Meredith,et al.  The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.

[16]  Tian-mu Chen,et al.  A mathematical model for simulating the phase-based transmissibility of a novel coronavirus , 2020, Infectious Diseases of Poverty.

[17]  B. Chun Understanding and Modeling the Super-spreading Events of the Middle East Respiratory Syndrome Outbreak in Korea , 2016, Infection & chemotherapy.